HDAC inhibitor CUDC-101, Purity ≥98%

Cat. No.: X23-10-ZQ274

HDAC inhibitor CUDC-101, Purity ≥98%

Synonym: 1012054-59-9; CUDC-101; CUDC 101; CUDC101; 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide; HDAC inhibitor

  • MDL: MFCD15528940
  • CAS Number: 1012054-59-9
  • Compound CID: 24756910
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
CUDC-101, soluble in DMSO and insoluble in ethanol and water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC, HDAC1, EGFR, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, and HDAC7.
Molecular Weight
434.5
Molecular Formula
C24H26N4O4
Targets
HDAC: 4.4 nM; HDAC1: 4.5 nM; EGFR: 2.4 nM; HDAC10: 26.1 nM; HDAC2: 12.6 nM; HDAC3: 9.1 nM; HDAC4: 13.2 nM; HDAC5: 11.4 nM; HDAC6: 5.1 nM; HDAC7: 373 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 20 mg/mL (46.03 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CUDC-101 is used to explore its dual inhibition of HDACs and epidermal growth factor receptor (EGFR), promoting research into its therapeutic potential in cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.